Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01325792 · ClinicalTrials.gov registry record
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
A clinical trial, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- 104
- Enrollment target
NCT01325792 is a clinical trial that has completed, run by W.L.Gore & Associates. The registered enrollment target is 104 participants.
The verdict
NCT01325792 has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
Prospective, multicenter, observational study to evaluate performance of GORE® BIO-A® Tissue Reinforcement when used to reinforce midline fascial closure in single-staged open complex ventral incisional hernia repair.
Interventions
- DEVICE GORE® BIO-A® Tissue Reinforcement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01325792
The ClinicalTrials.gov registry entry for NCT01325792 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE® BIO-A® Tissue Reinforcement is the first listed.
NCT01325792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01325792 about?
NCT01325792 is a clinical study titled "Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement". Prospective, multicenter, observational study to evaluate performance of GORE® BIO-A® Tissue Reinforcement when used to reinforce midline fascial closure in single-staged open complex ventral incisional hernia repair.
What is the current status of trial NCT01325792?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2011-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01325792?
The interventions under investigation include: GORE® BIO-A® Tissue Reinforcement (DEVICE).
Who is sponsoring clinical trial NCT01325792?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.